$9.08
0.20[2.25%]
At close: Apr 19
$9.08
0[0.00%]
After Hours: 4:00PM EDT
89bio Stock (NASDAQ:ETNB), Analyst Ratings, Price Targets, Predictions
89bio Inc has a consensus price target of $29.91, established from looking at the 56 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, HC Wainwright & Co., and HC Wainwright & Co. on April 5, 2024, March 27, 2024, and March 13, 2024. With an average price target of $30.33 between Cantor Fitzgerald, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 234.07% upside for 89bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
Evercore ISI Group
Oppenheimer
RBC Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for 89bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/05/2024 | ETNB | Buy Now | 89bio | $9.08 | 219.38% | Cantor Fitzgerald | Kristen Kluska | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | ETNB | Buy Now | 89bio | $9.08 | 241.41% | HC Wainwright & Co. | Ed Arce | $31 → $31 | Maintains | Buy | Get Alert |
| 03/13/2024 | ETNB | Buy Now | 89bio | $9.08 | 241.41% | HC Wainwright & Co. | Ed Arce | $31 → $31 | Maintains | Buy | Get Alert |
| 03/07/2024 | ETNB | Buy Now | 89bio | $9.08 | 307.49% | Evercore ISI Group | Liisa Bayko | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/06/2024 | ETNB | Buy Now | 89bio | $9.08 | 307.49% | Evercore ISI Group | Liisa Bayko | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/05/2024 | ETNB | Buy Now | 89bio | $9.08 | — | Oppenheimer | Jay Olson | — | Maintains | Perform | Get Alert |
| 03/04/2024 | ETNB | Buy Now | 89bio | $9.08 | 219.38% | Cantor Fitzgerald | Kristen Kluska | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/01/2024 | ETNB | Buy Now | 89bio | $9.08 | 54.19% | RBC Capital | Brian Abrahams | $15 → $14 | Maintains | Sector Perform | Get Alert |
| 03/01/2024 | ETNB | Buy Now | 89bio | $9.08 | 241.41% | HC Wainwright & Co. | Ed Arce | $32 → $31 | Maintains | Buy | Get Alert |
| 01/12/2024 | ETNB | Buy Now | 89bio | $9.08 | 65.2% | RBC Capital | Brian Abrahams | → $15 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/20/2023 | ETNB | Buy Now | 89bio | $9.08 | 252.42% | HC Wainwright & Co. | Ed Arce | $35 → $32 | Maintains | Buy | Get Alert |
| 12/05/2023 | ETNB | Buy Now | 89bio | $9.08 | 285.46% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | ETNB | Buy Now | 89bio | $9.08 | 285.46% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | ETNB | Buy Now | 89bio | $9.08 | 164.32% | RBC Capital | Brian Abrahams | $27 → $24 | Maintains | Outperform | Get Alert |
| 10/12/2023 | ETNB | Buy Now | 89bio | $9.08 | 175.33% | UBS | Eliana Merle | $36 → $25 | Maintains | Buy | Get Alert |
| 10/11/2023 | ETNB | Buy Now | 89bio | $9.08 | 197.36% | RBC Capital | Brian Abrahams | $34 → $27 | Maintains | Outperform | Get Alert |
| 09/22/2023 | ETNB | Buy Now | 89bio | $9.08 | 274.45% | RBC Capital | Brian Abrahams | → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2023 | ETNB | Buy Now | 89bio | $9.08 | 296.48% | UBS | Eliana Merle | → $36 | Initiates | → Buy | Get Alert |
| 08/10/2023 | ETNB | Buy Now | 89bio | $9.08 | 285.46% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for 89bio (ETNB)?
The latest price target for 89bio (NASDAQ: ETNB) was reported by Cantor Fitzgerald on April 5, 2024. The analyst firm set a price target for $29.00 expecting ETNB to rise to within 12 months (a possible 219.38% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for 89bio (ETNB)?
The latest analyst rating for 89bio (NASDAQ: ETNB) was provided by Cantor Fitzgerald, and 89bio reiterated their overweight rating.
When was the last upgrade for 89bio (ETNB)?
The last upgrade for 89bio Inc happened on May 12, 2022 when Raymond James raised their price target to $12. Raymond James previously had an outperform for 89bio Inc.
When was the last downgrade for 89bio (ETNB)?
The last downgrade for 89bio Inc happened on January 12, 2024 when RBC Capital changed their price target from N/A to $15 for 89bio Inc.
When is the next analyst rating going to be posted or updated for 89bio (ETNB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 89bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 89bio was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.
Is the Analyst Rating 89bio (ETNB) correct?
While ratings are subjective and will change, the latest 89bio (ETNB) rating was a reiterated with a price target of $0.00 to $29.00. The current price 89bio (ETNB) is trading at is $9.08, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.